Kefir and Reduced Insulin Levels Doses used in studies
mL/day: 180 (median 180, IQR 180–180) — 1 study Time to effect
Median: 2.8 months · IQR 2.8 months–2.8 months · Range 2.8 months–2.8 months — Reported in 1 of 2 studies
2 of 2 papers Population: All (2) Unspecified (1) Clinical (1)
2023-05 Meta-Analysis · n = 314 Current drug targets 24(7) Farveh Yahyapoor Neda Haghighat Zahra Sohrabi Omid Asbaghi Mohammad Bagherniya Tannaz Jamialahmadi Amirhossein Sahebkar Kefir intake significantly reduced fasting insulin (WMD: -3.69 micro-IU/mL,95% CI: -6.30 to -1.07, p = 0.006, I² = 0.0%)
Effect Beneficial Effect size Large Significant Yes 2019-09-04 RCT Nutrients 11(9) Ezgi Bellikci-Koyu Banu Pınar Sarer-Yurekli Yakut Akyon Fadime Aydin-Kose Cem Karagozlu Ahmet Gokhan Ozgen Annika Brinkmann Andreas Nitsche Koray Ergunay Engin Yilmaz Zehra Buyuktuncer High evidence Rigorous Journal Clinical Fasting insulin, HOMA-IR, TNF-α, IFN-γ, and systolic and diastolic blood pressure showed a significant decrease by the intervention of kefir (p ≤ 0.05, for each). However, no significant difference was obtained between the kefir and unfermented milk groups (p > 0.05 for each).
Effect Beneficial Effect size Small Significant Yes Dose 180 mL/day